These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29396095)

  • 1. Consolidation and maintenance in follicular lymphoma: radioimmunotherapy revisited?
    Gordon LI
    Lancet Haematol; 2018 Mar; 5(3):e96-e97. PubMed ID: 29396095
    [No Abstract]   [Full Text] [Related]  

  • 2. Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?
    Chatal JF; Kraeber-Bodéré F; Barbet J
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1236-9. PubMed ID: 18330570
    [No Abstract]   [Full Text] [Related]  

  • 3. Advancing radioimmunotherapy and its future role in non-Hodgkin lymphoma.
    Reagan PM; Friedberg JW
    Future Oncol; 2015; 11(10):1543-53. PubMed ID: 25963431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy in follicular lymphoma.
    Illidge T; Morschhauser F
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):279-93. PubMed ID: 21658624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving radioimmunotherapy forward for follicular lymphoma.
    Witzig TE
    J Clin Oncol; 2013 Jan; 31(3):294-6. PubMed ID: 23233712
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatment may eradicate virulent lymphoma. A single course of infections kills cancers, with minimal side-effects; positive responses immediate.
    Health News; 2005 May; 11(5):6-8. PubMed ID: 15887314
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
    Dillman RO
    Curr Hematol Rep; 2003 Jan; 2(1):30-7. PubMed ID: 12901152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted destruction of lymphomas with the aid of radioimmunotherapy. Tumor antibodies isotope taxi].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373026
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab maintenance versus radio-immunotherapy consolidation in first remission follicular non-Hodgkin lymphoma.
    Hagenbeek A
    Transfus Apher Sci; 2013 Aug; 49(1):43. PubMed ID: 23932512
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma--role of radioimmunotherapy.
    Dreyling M; Trümper L; von Schilling C; Rummel M; Holtkamp U; Waldmann A; Wehmeyer J; Freund M
    Ann Hematol; 2007 Feb; 86(2):81-7. PubMed ID: 17068667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management options for follicular lymphoma: observe; R-CHOP; B-R; others?
    McLaughlin P
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S91-5. PubMed ID: 22035757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunotherapy in non-Hodgkin's lymphoma. With focus on anti-CD20 treatment].
    de Nully Brown P; Jurlander J; Lindén O; Hansen M
    Ugeskr Laeger; 2005 Oct; 167(41):3867-9. PubMed ID: 16221425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
    Zinzani PL; d'Amore F; Bombardieri E; Brammer C; Codina JG; Illidge T; Jurczak W; Linkesch W; Morschhauser F; Vandenberghe E; Van Hoof A
    Eur J Cancer; 2008 Feb; 44(3):366-73. PubMed ID: 18194857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy in follicular lymphoma: an update.
    Mace JR
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):394-6. PubMed ID: 22895242
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of follicular lymphoma].
    Buske C; Unterhalt M; Hiddeman W
    Internist (Berl); 2007 Apr; 48(4):372-81. PubMed ID: 17287964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
    Morschhauser F; Radford J; Van Hoof A; Vitolo U; Soubeyran P; Tilly H; Huijgens PC; Kolstad A; d'Amore F; Gonzalez Diaz M; Petrini M; Sebban C; Zinzani PL; van Oers MH; van Putten W; Bischof-Delaloye A; Rohatiner A; Salles G; Kuhlmann J; Hagenbeek A
    J Clin Oncol; 2008 Nov; 26(32):5156-64. PubMed ID: 18854568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: let the tail wag the dog: the case for radioimmunotherapy of low-grade follicular lymphoma.
    Plastaras JP; Glatstein E; Schuster SJ
    Oncologist; 2008 Jun; 13(6):655-6. PubMed ID: 18586920
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab).
    Cooney J; Stiff P; Kaminski M
    Bone Marrow Transplant; 2002 Mar; 29(6):523-5. PubMed ID: 11960274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.
    Grgic A; Nestle U; Scheidhauer K; Puskas C; Ballek E; Hohloch K; Schubert J; König J; Pinkert J; Truemper L; Hellwig D; Kirsch CM
    Nuklearmedizin; 2011; 50(1):39-47. PubMed ID: 21057722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas.
    Forrer F; Oechslin-Oberholzer C; Campana B; Herrmann R; Maecke HR; Mueller-Brand J; Lohri A
    J Nucl Med; 2013 Jul; 54(7):1045-52. PubMed ID: 23572496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.